Initial Treatment for Cerebral Sinus Venous Thrombosis (CVST)

Diagnostic Confirmation

The American Heart Association recommends confirming the diagnosis with appropriate imaging, such as MRI with MR venography, which is the preferred initial imaging modality 2, 3
CT venography can be used if MRI is not readily available, as suggested by the American Heart Association 2
Catheter angiography may be needed in select cases with high clinical suspicion but negative initial imaging, according to the American Association of Neurological Surgeons 4

The American Heart Association recommends immediate anticoagulation with either intravenous unfractionated heparin (UFH) or subcutaneous low-molecular-weight heparin (LMWH) as first-line therapy 1, 5
The presence of intracerebral hemorrhage related to CVST is NOT a contraindication to anticoagulation, as stated by the American Heart Association 1, 2, 5

For patients with neurological stability or improvement, the American Heart Association recommends continuing anticoagulation with oral anticoagulants after initial heparin therapy 2, 3
The American College of Chest Physicians suggests that the duration of anticoagulation depends on underlying etiology, with 3-6 months for transient risk factors 1, 6
The American College of Chest Physicians also recommends indefinite (lifelong) anticoagulation for severe thrombophilia or recurrent thrombosis 6

All patients should be admitted to a stroke unit for close monitoring and specialized care, as recommended by the American Heart Association 5
The American Heart Association suggests investigating underlying prothrombotic conditions, as this affects treatment duration 7
The British Medical Journal notes that failure to recognize deterioration can occur in some patients with CVST, particularly those with cerebral venous sinus thrombosis 8